最近在分子理解和治疗 facioscapulohumeral 肌肉发育不良的进展
Roy Augustinus1, Nicole Voet2, Jessica C de Greef1
1Department of Human Genetics, Leiden University Medical Center, Leiden.
Current opinion in neurology
|June 5, 2025
概括
面肌肉发育不良 (FSHD) 研究正在推进,专注于分子理解和针对DUX4基因表达的新疗法. 目前的努力旨在精确治疗和改善这种遗传性肌肉病的症状管理.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 面骨肌缩症 (FSHD) 是一种渐进的遗传性肌肉病,目前没有治愈方法.
- 了解FSHD的分子基础对于开发有效的治疗方法至关重要.
研究的目的:
- 审查最近在FSHD分子理解方面的进展.
- 突出FSHD治疗干预措施的进展.
主要方法:
- 对FSHD最近的分子研究进行分析.
- 评估临床前模型,如用于药物查的3D骨肌肉.
- 审查当前的治疗策略,包括分子和基因疗法.
主要成果:
- 人们越来越了解FSHD的复杂性,并揭示了新的治疗点.
- 3D骨肌模型有助于研究分子通路和药物发现.
- 研究正在研究抑制DUX4基因活性及其下游效应的疗法.
结论:
- 异常的DUX4基因表达是FSHD的原因,尽管机制仍在被阐明.
- 了解关键蛋白质和基因的进步为未来的治疗提供了潜力.
- 目前的FSHD研究和临床试验强调分子方法,基因疗法和症状管理,表明向精准医学转变.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
Disorders of the Skeletal Muscle
1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Cystic Fibrosis: Management
434
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
434


